Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a Global Rating Scale for Inflammatory Bowel Disease.
Bitton A, Devitt KS, Bressler B, Heatherington J, Jairath V, Jones J, Moayyedi P, Weizman AV, Dubé C, MacIntosh D, Nguyen GC. Bitton A, et al. Among authors: heatherington j. J Can Assoc Gastroenterol. 2019 Jun 11;3(1):4-16. doi: 10.1093/jcag/gwz017. eCollection 2020 Feb. J Can Assoc Gastroenterol. 2019. PMID: 34169223 Free PMC article.
Innovative Care for Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Use of Bedside Intestinal Ultrasound to Optimize Management.
Lu C, Ma C, Ingram RJM, Chan M, Kheirkhahrahimabadi H, Martin ML, Seow CH, Kaplan GG, Heatherington J, Devlin SM, Panaccione R, Novak KL. Lu C, et al. Among authors: heatherington j. J Can Assoc Gastroenterol. 2022 Mar 10;6(1):e1-e6. doi: 10.1093/jcag/gwac006. eCollection 2023 Feb. J Can Assoc Gastroenterol. 2022. PMID: 36785574 Free PMC article.
Retraction notice to: PS124-Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (PSC) in Individuals with Inflammatory Bowel Disease [J Hepatol 64 (2016) S199].
Eksteen B, Heatherington J, Oshiomogo J, Panaccione R, Kaplan G, Ghosh S. Eksteen B, et al. Among authors: heatherington j. J Hepatol. 2017 Jan;66(1):254. doi: 10.1016/j.jhep.2016.10.020. Epub 2016 Dec 15. J Hepatol. 2017. PMID: 28042931 No abstract available.
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease.
Kotze PG, Ma C, Almutairdi A, Al-Darmaki A, Devlin SM, Kaplan GG, Seow CH, Novak KL, Lu C, Ferraz JGP, Stewart MJ, Buresi M, Jijon H, Mathivanan M, Heatherington J, Martin ML, Panaccione R. Kotze PG, et al. Among authors: heatherington j. Aliment Pharmacol Ther. 2018 Sep;48(6):626-637. doi: 10.1111/apt.14919. Epub 2018 Jul 31. Aliment Pharmacol Ther. 2018. PMID: 30063077
Bedside Intestinal Ultrasound Performed in an Inflammatory Bowel Disease Urgent Assessment Clinic Improves Clinical Decision-Making and Resource Utilization.
St-Pierre J, Delisle M, Kheirkhahrahimabadi H, Goodsall TM, Bryant RV, Christensen B, Vaughan R, Al-Ani A, Ingram RJM, Heatherington J, Carter D, Lu C, Ma C, Novak KL. St-Pierre J, et al. Among authors: heatherington j. Crohns Colitis 360. 2023 Sep 21;5(4):otad050. doi: 10.1093/crocol/otad050. eCollection 2023 Oct. Crohns Colitis 360. 2023. PMID: 37809033 Free PMC article.
RETRACTED: Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (Psc) in Individuals with Inflammatory Bowel Disease.
Eksteen B, Heatherington J, Oshiomogo J, Panaccione R, Kaplan G, Ghosh S. Eksteen B, et al. Among authors: heatherington j. J Hepatol. 2016;64(2S):S199. doi: 10.1016/S0168-8278(16)01707-4. Epub 2016 Sep 22. J Hepatol. 2016. Retraction in: J Hepatol. 2017 Jan;66(1):254. doi: 10.1016/j.jhep.2016.10.020 PMID: 27769522 Retracted.
14 results